Challenges in Diagnosing Hepatic Encephalopathy

Neurochemical Research

Volumn 40, Issue 2, 2015, Pages 265-273

  Weissenborn, K ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Concomitant disorders of liver cirrhosis; Differential diagnosis of hepatic encephalopathy; Psychometric tests

Indexed keywords

BRAIN DYSFUNCTION; BRAIN FUNCTION; CLINICAL FEATURE; COGNITIVE DEFECT; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; SENSITIVITY AND SPECIFICITY; CLASSIFICATION; COMPLICATION; MOTOR DYSFUNCTION;

COGNITION DISORDERS; HEPATIC ENCEPHALOPATHY; HUMANS; MOTOR DISORDERS;

EID: 84922722215     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-014-1416-x     Document Type: Review

References (61)

1. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT (2002) Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35:716–721
2. Atterbury CE, Maddrey WC, Conn HO (1978) Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis 23:398–406
3. Zeegen R, Drinkwater JE, Dawson AM (1970) Method for measuring cerebral dysfunction in patients with liver disease. Br Med J 2:633–636
4. Lockwood AH (2000) “What’s in a name?” Improving the care of cirrhotics. J Hepatol 32(5):859–861
5. Hassanein TI, Hilsabeck RC, Perry W (2008) Introduction to the hepatic encephalopathy scoring algorithm (HESA). Dig Dis Sci 53(2):529–538
6. Hassanein T, Blei AT, Perry W, Hilsabeck R, Stange J, Larsen FS, Brown RS Jr, Caldwell S, McGuire B, Nevens F, Fontana R (2009) Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. Am J Gastroenterol 104(6):1392–1400
7. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen K, Weissenborn K, Wong P (2014) Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the European association for the study of the liver. Hepatology 60(2):715–735
8. Krieger S, Jauß M, Jansen O, Theilmann L, Geißler M, Krieger D (1996) Neuropsychiatric profile and hyperintense globus pallidus on T1-weighted magnetic resonance images in liver cirrhosis. Gastroenterology 111:147–155
9. Tryc AB, Goldbecker A, Berding G, Rümke S, Afshar K, Shahrezaei GH, Pflugrad H, Barg-Hock H, Strassburg CP, Hecker H, Weissenborn K (2013) Cirrhosis-related parkinsonism: prevalence, mechanisms and response to treatments. J Hepatol 58(4):698–705
10. Mahlknecht P, Hotter A, Hussl A, Esterhammer R, Schocke M, Seppi K (2010) Significance of MRI in diagnosis and differential diagnosis of Parkinson’s disease. Neurodegener Dis 7(5):300–318
11. Isaias IU, Antonini A (2010) Single-photon emission computed tomography in diagnosis and differential diagnosis of Parkinson’s disease. Neurodegener Dis 7(5):319–329
12. Ferrara J, Jankovic J (2009) Acquired hepatocerebral degeneration. J Neurol 256:320–332
13. Pinarbasi B, Kaymakoglu S, Matur Z, Akyuz F, Demir K, Besisik F et al (2009) Are acquired hepatocerebral degeneration and hepatic myelopathy reversible? J Clin Gastroenterol 43:176–181
14. Fernandez-Rodriguez R, Contreras A, de Villoria JG, Grandas F (2010) Acquired hepatocerebral degeneration: clinical characteristics and MRI findings. Eur J Neurol 17:1463–1470
15. Burkhard PR, Delavelle J, Du Pasquier R, Spahr L (2003) Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration. Arch Neurol 60:521–528
16. Weissenborn K, Tietge UJ, Bokemeyer M, Mohammadi B, Bode U, Manns MP, Caselitz M (2003) Liver transplantation improves hepatic myelopathy: evidence by three cases. Gastroenterology 124:346–351
17. Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K (2009) International society for hepatic encephalopathy and nitrogen metabolism (ISHEN). Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29:629–635
18. Schomerus H, Hamster W (1998) Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis 13:361–377
19. Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773
20. Weissenborn K, Heidenreich S, Giewekemeyer K, Rückert N, Hecker H (2003) Memory function in early hepatic encephalopathy. J Hepatol 39(3):320–325
21. Summerskill WHJ, Davidson EA, Sherlock S, Steiner RE (1956) The neuropsychiatric syndrome associated with hepatic cirrhosis and an extensive portal collateral circulation. Q J Med 25(98):245–266
22. Adrogué HJ, Madias NE (2000) Hyponatremia. NEJM 342(21):1581–1589
23. Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA (2004) Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 61:661–666
24. Tryc AB, Alwan G, Bokemeyer M, Goldbecker A, Hecker H, Haubitz M, Weissenborn K (2011) Cerebral metabolic alterations and cognitive dysfunction in chronic kidney disease. Nephrol Dial Transplant 26(8):2635–2641
25. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP (2005) The effects of type 1 diabetes on cognitive performance: a meta-analysis. Diabetes Care 28(3):726–735
26. Alonso J, Córdoba J, Rovira A (2014) Brain magnetic resonance in hepatic encephalopathy. Semin Ultrasound CT MR 35(2):136–152
27. Gilberstadt SJ, Gilberstadt H, Zieve L, Buegel B, Collier RO Jr, McClain CJ (1980) Psychomotor performance defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 140:519–521
28. Rikkers L, Jenko P, Rudman D, Freides D (1978) Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism. Gastroenterology 75:462–469
29. Rehnström S, Simert G, Hansson JA, Johnson G, Vang J (1977) Chronic hepatic encephalopathy. A psychometric study. Scand J Gastroenterol 12:305–311
30. Schomerus H, Hamster W, Blunck H, Reinhard U, Meyer K, Dölle W (1981) Latent portasystemic encephalopathy: I. Nature of cerebral functional defects and their effect on fitness to drive. Dig Dis Sci 26:622–630
31. Angeli P, Wong F, Watson H, Gines P (2006) Hyponatremia in cirrhosis: results of a patient population survey. Hepatology 44:1535–1542
32. Cordoba J, Garcia-Martinez R, Simon-Talero M (2010) Hyponatremic and hepatic encephalopathies: similarities, differences and coexistence. Met Brain Dis 25:73–80
33. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH (2000) Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 32:209–217
34. Kril JJ, Butterworth RF (1997) Diencephalic and cerebellar pathology in alcoholic and non-alcoholic patients with end-stage liver disease. Hepatology 26:837–841
35. Sullivan EV, Rosenbloom MJ, Pfefferbaum A (2000) Pattern of motor and cognitive deficits in detoxified alcoholic men. Alcohol Clin Exp Res 24:611–621
36. Weissenborn K, Tryc AB, Heeren M, Worthmann H, Pflugrad H, Berding G, Bokemeyer M, Tillmann HL, Goldbecker A (2009) Hepatitis C virus infection and the brain. Metab Brain Dis 24(1):197–210
37. Newton JL, Hollingsworth KG, Taylor R, El-Sharkawy AM, Khan ZU, Pearce R, Sutcliffe K, Okonkwo O, Davidson A, Burt J, Blamire AM, Jones D (2008) Cognitive impairment in primary biliary cirrhosis: symptom impact and potential etiology. Hepatology 48:541–549
38. Hamster W (1982) Neuropsychologie der Latenten Postosystemischen Enzephalopathie. Medizinische Fakultät, Universität Tübingen, Habilitationsschrift
39. Goldbecker A, Weissenborn K, Shahrezaei GH, Afshar K, Rümke S, Barg-Hock H, Strassburg CP, Hecker H, Tryc AB (2013) Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut 62(10):1497–1504
40. Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, Ubiali E, Amodio P, members of the ISHEN commission on Neurophysiological Investigations (2009) Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29(6):789–796
41. Amodio P, Del Piccolo F, Petteno E, Mapelli D, Angeli P, Iemmolo R, Muraca M, Musto C, Gerunda G, Rizzo C, Merkel C, Gatta A (2001) Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 35:37–45
42. Weissenborn K (1991) Neurophysiological methods in the diagnosis of early hepatic encephalopathy. In: Bengtsson F, Jeppsson B, Almdahl T, Vilstrup H (eds) Progress in hepatic encephalopathy and metabolic nitrogen exchange. CRC Press, Boca Raton, pp 27–39
43. Marchetti P, D’Avanzo C, Orsato R, Montagnese S, Schiff S, Kaplan PW, Piccione F, Merkel C, Gatta A, Sparacino G, Toffolo GM, Amodio P (2011) Electroencephalography in patients with cirrhosis. Gastroenterology 141(5):1680–1689
44. Quero JC, Hartmann IJ, Meulstee J, Hop WC, Schalm SW (1996) The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis. Hepatology 24:556–560
45. Van Der Rijt CC, Schalm SW, De Groot GH, De Vlieger M (1984) Objective measurement of hepatic encephalopathy by means of automated EEG analysis. Electroencephalogr Clin Neurophysiol 57:423–426
46. Kircheis G, Wettstein M, Timmermann L, Schnitzler A, Häussinger D (2002) Critical flicker frequency for quantification of low-grade hepatic encephalopathy. Hepatology 35(2):357–366
47. Romero-Gómez M, Córdoba J, Jover R, del Olmo JA, Ramírez M, Rey R, de Madaria E, Montoliu C, Nuñez D, Flavia M, Compañy L, Rodrigo JM, Felipo V (2007) Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45(4):879–885
48. Dhiman RK, Kurmi R, Thumburu KK, Venkataramarao SH, Agarwal R, Duseja A, Chawla Y (2010) Diagnosis and prognostic significance of minimal hepatic encephalopathy in patients with cirrhosis of liver. Dig Dis Sci 55(8):2381–2390
49. Montagnese S, Schiff S, Amodio P (2014) A quick diagnosis of hepatic encephalopathy: fact or fiction? Hepatology. doi:10.1002/hep.27127
50. Randolph C (1998) The repeatable battery for the assessment of neuropsychological status (RBANS). The Psychological Corporation, San Antonio
51. Randolph C, Hilsabeck R, Kato A, Kharbanda P, Li YY, Mapelli D, Ravdin LD, Romero-Gomez M, Stracciari A, Weissenborn K, International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) (2009) Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 29(5):629–635
52. Amodio P, Del Piccolo F, Marchetti P, Angeli P, Iemmolo R, Caregaro L, Merkel C, Gerunda G, Gatta A (1999) Clinical features and survivial of cirrhotic patients with subclinical cognitive alterations detected by the number connection test and computerized psychometric tests. Hepatology 29(6):1662–1667
53. Amodio P, Pellegrini A, Amistà P, Luise S, Del Piccolo F, Mapelli D, Montagnese S, Musto C, Valenti P, Gatta A (2003) Neuropsychological–neurophysiological alterations and brain atrophy in cirrhotic patients. Metab Brain Dis 18(1):63–78
54. Bajaj JS, Saeian K, Verber MD, Hischke D, Hoffmann RG, Franco J, Varma RR, Rao SM (2007) Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102(4):754–760
55. Amodio P, Ridola L, Schiff S, Montagnese S, Pasquale C, Nardelli S, Pentassuglio I, Trezza M, Marzano C, Flaiban C, Angeli P, Cona G, Bisiacchi P, Gatta A, Riggio O (2010) Improving the inhibitory control task to detect minimal hepatic encephalopathy. Gastroenterology 139(2):510–518
56. Elsass P, Christensen SE, Ranek L, Theilgaard A, Tygstrup N (1981) Continuous reaction time in patients with hepatic encephalopathy. A quantitative measure of changes in consciousness. Scand J Gastroent 16:441–447
57. Elsass P, Christensen SE, Jorgensen F, Mortensen EL, Vilstrup H (1984) Number connection test and continuous reaction times in assessment of organic and metabolic encephalopathy: a comparative study. Acta pharmacol et toxicol 54:115–119
58. Lauridsen MM, Grønbæk H, Næser EB, Leth ST, Vilstrup H (2012) Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis 27(4):559–565
59. Lauridsen MM, Jepsen P, Vilstrup H (2011) Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis 26(2):135–139
60. Lauridsen MM, Thiele M, Kimer N, Vilstrup H (2013) The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy. Metab Brain Dis 28(2):231–234
61. Strauss E, Tramote R, Silva EP, Caly WR, Honain NZ, Maffei RA, de Sa MF (1992) Double-blind randomized clinical trial comparing neomycin and placebo in the treatment of exogenous hepatic encephalopathy. Hepatogastroenterology 39(6):542–545